Ionis, AstraZeneca in antisense kidney disease deal

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) granted AstraZeneca plc (LSE:AZN; NYSE:AZN) worldwide

Read the full 104 word article

User Sign In